Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz +8 more
wiley +1 more source
Characterization of Mast2 kinase defines structural features, regulation, and substrates. [PDF]
Lemke MC +15 more
europepmc +1 more source
Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown +2 more
wiley +1 more source
Dexpanthenol mitigates trauma-induced lung injury by modulating RIPK1/RIPK3/MLKL-mediated necroptosis in rats. [PDF]
Camas HE +9 more
europepmc +1 more source
Integrated Expression Analysis May Support Serine/Threonine Kinases as Common Hub Genes in Breast Cancer. [PDF]
Ekhtiyari MS +7 more
europepmc +1 more source
Comprehensive Analysis of the Putative Substratome of FAM20C, the Master Serine Kinase of the Secretory Pathway. [PDF]
Cesaro L +6 more
europepmc +1 more source
Decoding SR protein regulation: kinases, phosphatases, and therapeutic targeting strategies. [PDF]
Liu N +3 more
europepmc +1 more source
Emerging role of DYRK1A as a target in cardiovascular diseases (Review). [PDF]
Yu L, Cheng Q, Wu J.
europepmc +1 more source
Let the peptides shine: SOX (Sulfonamido-OXine)-labelled peptides for direct kinase and phosphatase monitoring. [PDF]
Papagora LE, Cochrane SA.
europepmc +1 more source

